Thalidomide in 42 Patients with Prurigo Nodularis Hyde

Publisher： Karger

E-ISSN： 1421-9832|223|2|107-112

ISSN： 1018-8665

Source： Dermatology, Vol.223, Iss.2, 2011-09, pp. : 107-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extensive Prurigo Nodularis: Characterization and Etiology

By  

Dermatology, Vol. 228, Iss. 3, 2014-03 ,pp. : 276-280

Karger

Access to resources Recommend Favorite

Evaluation of the Antipruritic Effects of Topical Pimecrolimus in Non-Atopic Prurigo Nodularis: Results of a Randomized, Hydrocortisone-Controlled, Double-Blind Phase II Trial

By  

Dermatology, Vol. 227, Iss. 4, 2013-11 ,pp. : 353-360

Karger

Access to resources Recommend Favorite

Antinuclear Antibodies in Patients with Prurigo Pigmentosa: A Linkage or a Coincidence?

By  

Dermatology, Vol. 218, Iss. 1, 2008-10 ,pp. : 90-91

Karger

Access to resources Recommend Favorite

Scleromyxedema: Successful Treatment with Thalidomide in Two Patients

By  

Dermatology, Vol. 214, Iss. 1, 2006-12 ,pp. : 58-60

Karger

Access to resources Recommend Favorite

Prurigo in Dermatomyositis

By  

Dermatology, Vol. 217, Iss. 4, 2008-10 ,pp. : 378-379

Karger

Access to resources Recommend Favorite